On Monday (9), the influenza vaccination campaign in Mogi das Cruzes was expanded to include new target audiences, according to information received from the Municipal Health Department.
As of today, the following groups can receive the immunization agent: the indigenous peoples and communities of Quilombola; teachers and workers in other jobs in children’s regular, primary, secondary and higher schools; persons with disabilities and comorbidities)According to the list below).
Education professionals must provide proof of employment in schools, such as a payment receipt or badge, and persons with disabilities and/or comorbidities must bring a prescription, tests, report, or other medical document proving their condition. Indigenous or Quilombolas also need to provide proof of ethnicity.
The vaccination campaign continues in all health units and in Pró-Hiper, with the possibility of access by car or on foot, from 9 am to 4 pm. All adults must appear with a personal document containing photo, CPF and proof of previous doses against Covid-19 because, if applicable and depending on the unit, you can carry out or indicate the request.
Clinical risk classes with seasonal influenza vaccine indication
|Clinical Risk Class||Indications|
|Chronic respiratory disease||asthma using inhaled or systemic corticosteroids (moderate or severe); chronic obstructive pulmonary disease; bronchiectasis; cystic fibrosis; interstitial lung disease; bronchopulmonary dysplasia; pulmonary arterial hypertension; Children with chronic lung disease of prematurity.|
|Chronic heart disease||congenital heart disease; Systemic arterial hypertension with comorbidity;ischemic heart disease; Congestive heart.|
|Chronic kidney failure||kidney disease in stages 3,4 and 5; nephrotic syndrome; Patient on dialysis.|
|chronic liver disease||Biliary atresia, chronic hepatitis, cirrhosis.|
|chronic nervous disease||Situations in which respiratory functions may be compromised by a neurological disease; Consider the individual clinical needs of patients including: stroke, individuals with cerebral palsy, multiple sclerosis, and similar conditions; hereditary and degenerative diseases of the nervous or muscular system; severe nervous weakness;|
|diabetic||Type 1 and type 2 diabetes mellitus in medication use.|
|immunity||Congenital or acquired immunodeficiency: suppression of immunity by disease or medication|
|ghee||Obesity of the third degree.|
|planted||solid organs; Bone Marrow.|
|trisomy vector||Down Syndrome, Klinefelter Syndrome, Wakani Syndrome, Among the Trisomy|
Doses update against Covid-19 continues in Mogi das Cruzes before Click Vaccine.
The deadline for applying a second dose for those vaccinated with Astrazeneca is eight weeks after the first dose; For Pfizer 12 years + 21 days after first dose; For Pfizer Children (5-11 years old), this is eight weeks after the first dose; For Coronavac 18 years or older, 15 days after the first dose; And for Coronavac from 6 to 17 years of age, 28 days after the first dose.
The deadlines for applying a booster dose for people over 18 years of age are four months for those vaccinated with the first and second doses of AstraZeneca, Pfizer, or Coronavac. The same period is necessary for the application of the additional dose for elderly people aged 60 years and over.
Anyone with any questions can contact SIS 160.
This story was last updated on May 9, 2022 6:53 PM
“Music fanatic. Very humble explorer. Analyst. Travel fanatic. Extreme television teacher. Gamer.”
How to improve mood and ward off frustration
The dominant strain has new symptoms that are manifested at night
Covid-19: DF records 1,499 new cases and one more death | Federal District